The anti-PD-L1 antibody (not specified in the paper) was conjugated to liposomes loaded with oxaliplatin, a third-generation platinum anti-cancer drug, and miRNA-130a, which is involved in the pathogenesis of different cancers. Here, CD274 is linked to cancer.